Provided herein are compounds of the formula (I): ##STR00001## wherein
R.sup.1-R.sup.8 are as described herein, R.sup.4 being aryl or heteroaryl
Such compounds are particularly useful in the treatment of a disorder
which is created by or is dependent upon decreased availability of
serotonin, norepinephrine or dopamine.